Liposomal Irinotecan and Apatinib in ES-SCLC

Clinical trial NCT06749691 · RECRUITING

Trial details

NCT number: NCT06749691
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage

Start date: 2024-12-28
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.